ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis Provides Additional Phase III Data for MS Drug Siponimod: Prepares to Seek FDA Approval
April 23, 2018Novartis released new information that showed the drug consistently reduced the risk of confirmed disability progression in secondary progressive multiple sclerosis (SPMS) patients. -
Biogen MS drug hit by EU safety restriction
July 11, 2017Biogen’s Zinbryta multiple sclerosis drug has suffered a serious setback after European regulators restricted its use because of liver safety concerns.
Pharma Sources Insight January 2025
